AI-enabled iontronic devices for neurological diseases
Innovative Solution
Panaxium’s proprietary brain-machine interface (BMI) platform is built for surgeons and neurologists to directly intervene, treat the injury, and leave the patient to return to normalcy.
Solution Effectiveness
Panaxium’s platform is designed to guide the remapping of damaged functions to healthy brain regions
Investment Funding
Last Funding Stage
Seed
Total Funding Amount
$13.3M
Last Funding Amount
$5M
Last Funding Date
Apr 10, 2023
Startup Stage
Early-Stage
Lead Investors
Blueriver Capital, Ontario Brain Institute, Creative Destruction Lab, Incubateur Impulse
People
Founders
Bradley Schmidt
Pierre Leleux
CEO
Bradley Schmidt
Products
Demo Product or Complete Product?
Development
Awards and Recognitions
Awards
2022 Brain Innovation Days
Media Apperance
Biospace, Yahoo Finance, Medical Device Network
M&A and Collabs
Collab
Synaptive Medical Partners with Panaxium to Bring Real-Time Intelligent High-Resolution Cortical Mapping to Neurosurgical OR
